Skip to main navigation
Skip to search
Skip to main content
Discovery - the University of Dundee Research Portal Home
Home
Profiles
Research units
Research Outputs
Projects
Datasets
Theses
Activity
Press/Media
Research Facilities
Prizes
Search by expertise, name or affiliation
Metabolic antianginal agent ranolazine offers good symptom relief in a patient with inoperable severe aortic stenosis
Pandula Athauda-arachchi,
Chim Lang
Research output
:
Contribution to journal
›
Letter
›
peer-review
3
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Metabolic antianginal agent ranolazine offers good symptom relief in a patient with inoperable severe aortic stenosis'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Metabolic
100%
Symptom Relief
100%
Antianginal
100%
Ranolazine
100%
Severe Aortic Stenosis
100%
Hemodynamic Changes
50%
Angina
50%
Safe Use
50%
Aortic Stenosis
50%
Coronary Disease
50%
Surgical Valve Replacement
50%
Percutaneous Valve Therapy
50%
Ladies
50%
Medical Comorbidity
50%
Medicine and Dentistry
Antiangina Pectoris Agent
100%
Aortic Stenosis
100%
Ranolazine
100%
Hemodynamic
33%
Clinician
33%
Angina pectoris
33%
Coronary Artery Disease
33%
Percutaneous Valve
33%
Valve Replacement
33%
Comorbidity
33%